10-Q: Kewaunee Scientific Posts Strong Q1 Growth Driven by Nu Aire Acquisition

Kewaunee Scientific Corporation reported a significant increase in net sales and earnings for the first quarter, largely propelled by its recent acquisition of Nu Aire.

Summary

• Net sales surged by 46.9% to $71.1 million for the three months ended July 31, 2025, compared to $48.4 million in the prior year.
• Domestic sales increased 53.0% to $54.4 million, primarily due to the Nu Aire acquisition.
• International sales grew 30.2% to $16.8 million, driven by the commencement of large projects.
• Gross profit margin expanded to 29.4% from 25.8% in the prior year, attributed to the Nu Aire acquisition, improved manufacturing productivity, and cost-containment initiatives.
• Net earnings attributable to Kewaunee Scientific Corporation rose 41.0% to $3.1 million, or $1.04 per diluted share, compared to $2.2 million, or $0.74 per diluted share, in the prior year.
• Operating profit increased 86.8% to $4.8 million.
• Order backlog stood at $205.0 million as of July 31, 2025, up from $159.4 million a year ago, but slightly down from $214.6 million at April 30, 2025.
• Cash provided by operating activities was $5.8 million, a significant improvement from cash used of $0.8 million in the prior year.
• The company is evaluating the impact of the recently enacted One Big Beautiful Bill Act (OBBBA) on its tax position.

Sentiment

Score: 8

Explanation: The company demonstrated strong financial performance with significant revenue and earnings growth, largely driven by a successful acquisition and improved margins. The positive shift in operating cash flow and robust backlog are strong indicators. While increased operating and interest expenses are noted, they are largely tied to strategic growth initiatives. The outlook acknowledges potential volatility but expresses confidence in long-term health.

Positives

• Substantial 46.9% increase in net sales, reaching $71.1 million.
• Significant expansion of gross profit margin to 29.4%, indicating improved operational efficiency and strategic benefits from the Nu Aire acquisition.
• Strong growth in net earnings attributable to Kewaunee Scientific Corporation, up 41.0% to $3.1 million.
• Diluted earnings per share increased by 40.5% to $1.04.
• Positive cash flow from operating activities of $5.8 million, a notable turnaround from a negative $0.8 million in the prior year.
• Order backlog remains robust at $205.0 million, indicating future revenue visibility.
• Successful integration of Nu Aire acquisition, contributing $19.7 million in revenue and $696,000 in net earnings for the quarter.
• Company is in compliance with all financial covenants under its Loan Agreement.

Negatives

• Operating expenses increased by 62.6% to $16.1 million, outpacing sales growth, primarily due to the Nu Aire acquisition and increased international operating expenses and SG&A costs.
• Interest expense more than doubled to $1.1 million, reflecting increased bank and other borrowings related to the Nu Aire acquisition.
• Order backlog decreased by 4.5% from $214.6 million at April 30, 2025, to $205.0 million at July 31, 2025.
• Cash used in financing activities shifted from providing $343,000 in the prior year to using $1.5 million, mainly for debt servicing.

Risks

• Ability to realize anticipated benefits from the Nu Aire acquisition.
• Competitive and general economic conditions, including disruptions from government mandates, domestically and internationally, as well as supplier constraints and other supply disruptions.
• Changes in customer demands and technological changes in operations or industry.
• Dependence on customers' required delivery schedules and risks related to fluctuations in operating results from quarter to quarter.
• Risks related to international operations, including foreign currency fluctuations.
• Changes in the legal and regulatory environment, and changes in raw materials and commodity costs (including steel, wood, and epoxy resin).
• Acts of terrorism, war, governmental action, natural disasters, and other Force Majeure events.
• Volatility in project delivery timelines, which may create uneven performance by quarter for the balance of fiscal year 2026.
• Uncertainty around government policy and evolving tariff structures.

Future Outlook

The company anticipates some volatility in project delivery timelines, which may create uneven performance by quarter for the balance of fiscal year 2026, despite a strong overall backlog. Management remains focused on both organic and inorganic growth, committing to strategic investments in people, processes, and technology to support sustainable growth. The company is confident that these investments and its healthy backlog will help navigate short-term headwinds and maintain long-term business health.

Management Comments

• Kewaunee's first quarter results for fiscal year 2026 demonstrate the Company's resilience in the face of challenging market conditions, including uncertainty around government policy, evolving tariff structures, and broader geopolitical upheaval.
• The Company remains focused on growth, both organically and inorganically, and is committed to making strategic investments in the people, processes, and technology that will support and enable this growth in a sustainable manner.
• The Company is confident that these strategic investments and its healthy backlog position the Company well to handle any anticipated short-term headwinds and maintain the long-term health of the business.

Industry Context

The company operates in the laboratory furnishings and technical products sector, which is influenced by laboratory construction projects and demand from life sciences, healthcare, and education. The Nu Aire acquisition significantly expands its product portfolio into biological safety cabinets and other essential lab equipment, positioning it to better meet diverse end-user needs and accelerate its vision of market leadership. The industry faces challenges from government policy uncertainty, evolving tariff structures, and geopolitical upheaval, which the company acknowledges may lead to project delivery volatility.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact from increased net earnings, EPS, and strong backlog, potentially supporting long-term value. Share repurchase program provides potential for capital return.
• Employees: Integration of Nu Aire employees into the company's control environment. Increased SG&A wages, benefits, incentive and stock-based compensation.
• Customers: Expanded product offerings and capabilities through the Nu Aire acquisition, allowing the combined organization to better meet diverse needs in laboratory furnishings and technical products.
• Creditors: Increased debt levels due to the Nu Aire acquisition, but the company is in compliance with all financial covenants.
• Suppliers: Potential for increased demand for raw materials due to higher sales and backlog, but also subject to supplier constraints and supply disruptions.

Next Steps

• Evaluate the full impact of the One Big Beautiful Bill Act (OBBBA) on its effective tax rate, deferred tax assets and liabilities, and future cash tax obligations.
• Continue integrating Nu Aire into its systems and control environment.
• Focus on organic and inorganic growth, making strategic investments in people, processes, and technology.
• Manage potential volatility in project delivery timelines for fiscal year 2026.
• Adopt ASU 2023-09 in fiscal year 2026 for income tax disclosures.
• Adopt ASU 2024-03 for annual disclosures in fiscal year 2028 and for interim disclosures in fiscal year 2029.
• A new lease is expected to commence in the second quarter of fiscal year 2026.
• Another new lease, entered into subsequent to July 31, 2025, will commence in the second quarter of fiscal year 2026.

Key Dates

Recommendation

The company demonstrated robust financial performance in Q1 FY2026, with significant top-line growth driven by the strategic Nu Aire acquisition and strong international sales. Gross profit margins expanded, and operating cash flow saw a substantial positive turnaround. While operating and interest expenses increased, they are largely attributable to the growth strategy. The healthy order backlog provides good revenue visibility, and management's commitment to organic and inorganic growth, coupled with strategic investments, positions the company well for sustained long-term health despite anticipated short-term volatility. The current results indicate successful integration and execution, making it an attractive investment.

Keywords

laboratory furniture, scientific equipment, Nu Aire acquisition, financial results, Q1 2026, SEC filing, KEQU, laboratory products, fume hoods, biological safety cabinets, industrial sectors, life sciences, healthcare, education